IL138775A0 - Methods and compositions for stabilizing acetylcholine compositions - Google Patents

Methods and compositions for stabilizing acetylcholine compositions

Info

Publication number
IL138775A0
IL138775A0 IL13877599A IL13877599A IL138775A0 IL 138775 A0 IL138775 A0 IL 138775A0 IL 13877599 A IL13877599 A IL 13877599A IL 13877599 A IL13877599 A IL 13877599A IL 138775 A0 IL138775 A0 IL 138775A0
Authority
IL
Israel
Prior art keywords
acetylcholine
compositions
buffered
stabilizing
product
Prior art date
Application number
IL13877599A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL138775A0 publication Critical patent/IL138775A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
IL13877599A 1998-04-29 1999-04-27 Methods and compositions for stabilizing acetylcholine compositions IL138775A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6955298A 1998-04-29 1998-04-29
PCT/EP1999/002846 WO1999055304A1 (en) 1998-04-29 1999-04-27 Methods and compositions for stabilizing acetylcholine compositions

Publications (1)

Publication Number Publication Date
IL138775A0 true IL138775A0 (en) 2001-10-31

Family

ID=22089751

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13877599A IL138775A0 (en) 1998-04-29 1999-04-27 Methods and compositions for stabilizing acetylcholine compositions

Country Status (25)

Country Link
US (1) US6261546B1 (xx)
EP (1) EP1073413B1 (xx)
JP (1) JP2002512945A (xx)
KR (1) KR100617429B1 (xx)
CN (1) CN1147289C (xx)
AT (1) ATE286380T1 (xx)
AU (1) AU745124B2 (xx)
BR (1) BR9910077A (xx)
CA (1) CA2327398C (xx)
CZ (1) CZ301969B6 (xx)
DE (1) DE69923063T2 (xx)
EE (1) EE04515B1 (xx)
ES (1) ES2235486T3 (xx)
HK (1) HK1034204A1 (xx)
HU (1) HU226104B1 (xx)
ID (1) ID26032A (xx)
IL (1) IL138775A0 (xx)
NO (1) NO20005372D0 (xx)
NZ (1) NZ507074A (xx)
PL (1) PL194092B1 (xx)
PT (1) PT1073413E (xx)
RU (1) RU2225199C2 (xx)
SI (1) SI1073413T1 (xx)
UA (1) UA72209C2 (xx)
WO (1) WO1999055304A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ577511A (en) * 2006-11-30 2012-04-27 Nihon Mediphysics Co Ltd 2-Phenyl-imidazo[1,2-a]pyridine derivatives substituted with a radioactive halogen substituent
US20130029919A1 (en) 2011-07-26 2013-01-31 Allergan, Inc. Two part formulation system for opthalmic delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009892A (en) * 1989-03-03 1991-04-23 Mckinzie James W Rapid miosis with control of intraocular pressure
US5565188A (en) 1995-02-24 1996-10-15 Nanosystems L.L.C. Polyalkylene block copolymers as surface modifiers for nanoparticles
US5612027A (en) 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber

Also Published As

Publication number Publication date
ES2235486T3 (es) 2005-07-01
ATE286380T1 (de) 2005-01-15
AU745124B2 (en) 2002-03-14
NO20005372L (no) 2000-10-25
EP1073413A1 (en) 2001-02-07
DE69923063T2 (de) 2005-12-22
PT1073413E (pt) 2005-04-29
RU2225199C2 (ru) 2004-03-10
AU4034099A (en) 1999-11-16
NZ507074A (en) 2004-02-27
SI1073413T1 (xx) 2005-08-31
CN1147289C (zh) 2004-04-28
HK1034204A1 (en) 2001-10-19
JP2002512945A (ja) 2002-05-08
CN1298295A (zh) 2001-06-06
UA72209C2 (en) 2005-02-15
CZ301969B6 (cs) 2010-08-18
KR100617429B1 (ko) 2006-08-30
EE200000625A (et) 2002-02-15
EE04515B1 (et) 2005-08-15
CZ20003961A3 (cs) 2001-01-17
HUP0100613A2 (hu) 2001-08-28
KR20010043121A (ko) 2001-05-25
PL194092B1 (pl) 2007-04-30
WO1999055304A1 (en) 1999-11-04
US6261546B1 (en) 2001-07-17
CA2327398C (en) 2008-12-30
PL343174A1 (en) 2001-07-30
BR9910077A (pt) 2000-12-26
ID26032A (id) 2000-11-16
CA2327398A1 (en) 1999-11-04
DE69923063D1 (de) 2005-02-10
NO20005372D0 (no) 2000-10-25
HU226104B1 (en) 2008-04-28
HUP0100613A3 (en) 2001-12-28
EP1073413B1 (en) 2005-01-05

Similar Documents

Publication Publication Date Title
ZA973647B (en) Inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them.
CA2200195A1 (en) Use of aromatase inhibitors for the production of a pharmaceutical agentfor treating a relative androgen deficiency in men
GR3030342T3 (en) Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase.
HUP9900728A2 (hu) Thrombin inhibitorhatású peptidszármazékok, eljárás előállításukra, és az ezeket tartalmazó gyógyszerkészítmények
HK1056510A1 (en) Minoxidil-containing preparations
IE43579L (en) Heteroaryl compounds
IL117091A (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof
HK1050535A1 (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
TW268937B (xx)
JO1696B1 (en) Acetamide derivatives
WO2002028829A3 (en) Peptide deformylase inhibitors
WO1998008505A8 (en) Pharmaceutical compounds
WO2001087287A3 (en) Use of pyrazole derivatives for treating infertility
GEP20084346B (en) Protein kinase c inhibitors
AU1869601A (en) Pharmaceutical compositions comprising trimegestone
CA2218663A1 (en) Benzisoxazole and indazole derivatives as antipsychotic agents
IL138775A0 (en) Methods and compositions for stabilizing acetylcholine compositions
ES2111272T3 (es) Mezclas herbicidas.
MXPA03001455A (es) Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
AU2002313478A1 (en) Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor
EP0869786A4 (en) PHARMACEUTICAL COMPOUNDS
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
PL356165A1 (en) Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees